Vanda Pharmaceuticals Settles HETLIOZĀ® Patent Litigation with MSN
Go back to Vanda Pharmaceuticals Settles HETLIOZĀ® Patent Litigation with MSN| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 5.44 +0.11 (2.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.33 | 52 Week High | $18.00 | |||
| Open | $5.34 | 52 Week Low | $6.91 | |||
| Day High | $5.50 | P/E | N/A | |||
| Day Low | $5.34 | EPS | $-0.67 | |||
| Volume | 876,347 | |||||

